Cytomyx Holdings PLC announces 3rd Quarter Results CAMBRIDGE, U.K., Aug. 24, 2004 (PRIMEZONE) -- CYTOMYX HOLDINGS PLC: Financial results for the third quarter ended 30 June 2004; U.S. figures have been based on the average conversion rate of...

Cytomyx Holdings PLC Announces Clinomics BioSciences, Cytomyx' US Subsidiary, in Research Collaboration with Moffitt Cancer Center CAMBRIDGE, U.K. and ALBANY, New York, July 13, 2004 (PRIMEZONE) -- Clinomics Biosciences, Inc., the wholly owned US subsidiary of Cytomyx Holdings plc (AIM:CYX), a leading provider of drug discovery...

Cytomyx Licenses Cell Lines from CellFactors CAMBRIDGE, U.K., April 20, 2004 (PRIMEZONE) -- For immediate release 20 April 2004 CYTOMYX HOLDINGS PLC CYTOMYX LICENSES CELL LINES FROM CELLFACTORS Cytomyx Holdings plc (AIM: CYX), the leading...

Cytomyx Licenses Cancer Database to AstraZeneca CAMBRIDGE, U.K., March 30, 2004 (PRIMEZONE) -- Cytomyx Holdings plc (LSE:CYX), the leading provider of drug discovery products and services, today announces that Clinomics Biosciences Inc, its...